BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 19584729)

  • 1. Pathogenesis of kidney disease in systemic lupus erythematosus.
    Bagavant H; Fu SM
    Curr Opin Rheumatol; 2009 Sep; 21(5):489-94. PubMed ID: 19584729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights from murine lupus: disassociation of autoimmunity and end organ damage and the role of T cells.
    Bagavant H; Fu SM
    Curr Opin Rheumatol; 2005 Sep; 17(5):523-8. PubMed ID: 16093828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes.
    Bagavant H; Deshmukh US; Wang H; Ly T; Fu SM
    J Immunol; 2006 Dec; 177(11):8258-65. PubMed ID: 17114504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage.
    Bagavant H; Deshmukh US; Gaskin F; Fu SM
    Scand J Immunol; 2004; 60(1-2):52-63. PubMed ID: 15238073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
    Seelen MA; Trouw LA; Daha MR
    Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):619-24. PubMed ID: 14564199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of tissue injury in lupus nephritis.
    Nowling TK; Gilkeson GS
    Arthritis Res Ther; 2011; 13(6):250. PubMed ID: 22192660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
    Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
    J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of activated lymphocyte-derived DNA accelerates and aggravates lupus nephritis in B6/lpr mice: a new approach to modify a lupus murine model.
    Zhu Y; Yue Y; Xiong S
    Clin Exp Immunol; 2018 Sep; 193(3):302-312. PubMed ID: 29704464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice.
    Xia W; Eltrich N; Vielhauer V
    Front Immunol; 2024; 15():1377913. PubMed ID: 38799420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
    Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into disease pathogenesis from mouse lupus genetics.
    Jørgensen TN; Gubbels MR; Kotzin BL
    Curr Opin Immunol; 2004 Dec; 16(6):787-93. PubMed ID: 15511674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
    Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
    Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner.
    Celhar T; Lu HK; Benso L; Rakhilina L; Lee HY; Tripathi S; Zharkova O; Ong WY; Yasuga H; Au B; Marlier D; Lim LHK; Thamboo TP; Mudgett JS; Mackey MF; Zaller DM; Connolly JE; Fairhurst AM
    Front Immunol; 2019; 10():1546. PubMed ID: 31354711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Lupus Nephritis: Clinical Implications.
    Munroe ME; James JA
    Semin Nephrol; 2015 Sep; 35(5):396-409. PubMed ID: 26573543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of lupus nephritis.
    Lech M; Anders HJ
    J Am Soc Nephrol; 2013 Sep; 24(9):1357-66. PubMed ID: 23929771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the role of renal resident cells in the pathogenesis of lupus nephritis.
    Kwok SK; Tsokos GC
    Korean J Intern Med; 2018 Mar; 33(2):284-289. PubMed ID: 29320847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of three major New Zealand Black-derived loci linked with Yaa-induced murine lupus nephritis.
    Kikuchi S; Fossati-Jimack L; Moll T; Amano H; Amano E; Ida A; Ibnou-Zekri N; Laporte C; Santiago-Raber ML; Rozzo SJ; Kotzin BL; Izui S
    J Immunol; 2005 Jan; 174(2):1111-7. PubMed ID: 15634937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.
    Mohan C; Putterman C
    Nat Rev Nephrol; 2015 Jun; 11(6):329-41. PubMed ID: 25825084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the immunopathogenesis of systemic lupus erythematosus.
    Tsokos GC; Lo MS; Costa Reis P; Sullivan KE
    Nat Rev Rheumatol; 2016 Nov; 12(12):716-730. PubMed ID: 27872476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.